Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.
- 1 January 1982
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 30 (10) , 3601-3616
- https://doi.org/10.1248/cpb.30.3601
Abstract
Thiazolidine-2,4-dione derivatives having 1 or 2 substituent(s) such as phenyl, heteryl and alkyl group(s) at the 5-position were synthesized and evaluated as aldose reductase inhibitors. Inhibition by the active compounds of the swelling of the lens in a rat-lens-culture assay was also measured. Among these compounds, a series of 5-(3,4-dialkoxyphenyl)thiazolidine-2,4-diones showed pronounced activities in both assays. Structure-activity relationships are discussed and a new approach to the synthesis of 5-arylthiazolidine-2,4-diones is described.This publication has 2 references indexed in Scilit:
- The effects of aldose reductase inhibitors on the metabolism of cultured monkey kidney epithelial cellsBiochemical Pharmacology, 1981
- Osmotic changes in experimental galactose cataractsExperimental Eye Research, 1962